Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Gastrointestinal bleeding (GIB) is an important clinical problem in recipients of ventricular assist devices (VAD), although data pertaining to the endoscopic evaluation and management of this complication are limited in the medical literature.
We sought to identify the most common endoscopic findings in VAD recipients with GIB, and to better define the diagnostic and therapeutic utility of endosopy for this patient population.
Twenty-six subjects with VAD and overt GIB were retrospectively identified. Clinical and endoscopic data were abstracted for each subject on to standardized forms in duplicate and independent fashion. Raw data and descriptive statistics were reported.
Non-peptic vascular lesions were the most common cause of GIB. A definitive cause of bleeding was identified by endoscopy in almost 60% of subjects. Endoscopic hemostasis was achieved in 14/15 patients in whom bleeding did not stop spontaneously. Rebleeding occurred in 50% of subjects and was successfully retreated or stopped spontaneously in all cases. Colonoscopy did not establish a definitive diagnosis or deliver hemostatic therapy in any case.
Vascular malformations account for the overwhelming majority of bleeding lesions in VAD patients with GIB. Endoscopy seems to be a safe and effective tool for diagnosing, risk stratifying, and treating this patient population, although multiple endoscopies may be necessary before therapeutic success, and the incidence of rebleeding is high. A prospective multi-center registry is necessary to establish evidence-based management algorithms for VAD recipients with GIB.
- Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443. CrossRef
- John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the Heartmate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227.
- Hill J, Farrar D, Hershon J, et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med. 1986;314:626–628. CrossRef
- Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896. CrossRef
- Long JW, Healy AH, Rasmusson BY, et al. Improving outcomes with long-term “destination” therapy using left ventricular assist devices. J Thorac Cardiovasc Surg. 2008;135:1353–1361. CrossRef
- Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105–109. CrossRef
- Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010;25:352–356. CrossRef
- Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;37:208–211. CrossRef
- Hayes HM, Dembo LG, Larbalestier R, O’Driscoll G. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience. Artif Organs. 2010;34:703–706. CrossRef
- Heyde EC. Gastrointestinal bleeding in aortic stenosis [letter]. N Engl J Med. 1958;259:196.
- Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquiredvon Willebrand’s disease the link? Lancet. 1992;340:35–37. CrossRef
- Cappell MS, Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Ann Intern Med. 1986;105:55–57.
- Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardio Thorac Surg. 2008;33:679–684. CrossRef
- Steinlechner B, Dworschak M, Birkenberg B, et al. Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg. 2009;87:131–137. CrossRef
- Klovaite J, Gustafsson F, Mortensen S, et al. Factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162–2167. CrossRef
- Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding
Digestive Diseases and Sciences
Volume 56, Issue 11 , pp 3241-3246
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Ventricular assist device
- Gastrointestinal hemorrhage
- Endoscopic evaluation
- Endoscopic hemostasis
- Industry Sectors
- Author Affiliations
- 1. Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI, 48109, USA
- 2. Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA
- 3. Division of Cardiac Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA